Skip to content
FacebookTwitterLinkedinYoutubeInstagram
  • Antibiotic Resistance
  • News and Updates
  • Partnerships
  • About NFID
  • Support NFID
NFID
  • Infectious Diseases
    • Column 1
      • Chickenpox (Varicella)
      • Chikungunya
      • Coronaviruses (COVID-19)
      • Dengue
      • Diphtheria
      • Ebola
      • Flu (Influenza)
      • Hepatitis
      • Hib Disease
    • Column 2
      • HIV/AIDS
      • HPV (Human Papillomavirus)
      • Japanese Encephalitis
      • Measles
      • Meningococcal Disease
      • Mpox
      • Mumps
      • Norovirus
      • Pneumococcal Disease
    • Column 3
      • Polio
      • Rabies
      • Respiratory Syncytial Virus (RSV)
      • Rotavirus
      • Rubella
      • Shingles (Herpes Zoster)
      • Tetanus
      • Tuberculosis (TB)
      • Whooping Cough (Pertussis)
      • Zika
  • Immunization
    • US Vaccine Recommendations
      • Child and Adolescent Immunization Schedule (Birth-18 Years)
      • Adult Immunization Schedule (19 Years and Older)
      • Parent-Friendly Schedule for Infants and Children (Birth-6 Years)
      • Parent-Friendly Schedule for Preteens and Teens (7-18 Years)
      • Infants/Children (Spanish)
      • Preteens/Teens (Spanish)
    • Vaccine Science and Safety
  • Handwashing
    • Hands In For Handwashing
  • Education and Events
    • Annual Conference on Vaccinology Research
    • Awards Gala and Silent Auction
    • Clinical Vaccinology Course
    • NFID Annual News Conference: Preventing Respiratory Disease This Fall and Winter
    • Webinars
  • Resources
    • Resource Library
    • En Español
    • Graphics
    • Contagious Chronicles
    • Infectious IDeas (Podcast)
    • Public Service Announcements
    • Real Stories, Real People
    • Surveys and Publications
  • Support NFID
  • Select Language

Coronaviruses

  1. Home
  2. Coronaviruses
  3. Page 11

April 13, 2021

Schaffner Report: COVID-19 Vaccine Safety and Effectiveness

NFID Medical Director William Schaffner, MD, answers timely questions about the latest data on COVID-19 vaccine safety and effectiveness

Learn More
April 13, 2021

NFID Statement on COVID-19 Vaccine Safety

FOR IMMEDIATE RELEASE Bethesda, MD (April 13, 2021)—The following statement can be attributed to William Schaffner, MD, medical director of the National Foundation for Infectious…

Learn More
April 6, 2021

What Have We Learned from COVID-19?

During World Immunization Week, NFID will host the virtual 2021 Annual Conference on Vaccinology Research (ACVR) on April 26-27, 2021, with presentations from leaders in the field of vaccinology, including three keynote lectures on the implications of the COVID-19 pandemic. Read more about the changes and challenges these renowned experts have seen throughout their remarkable careers …

Learn More
Public Service Announcements, Video

5 Tips to Help #StopTheSpread of COVID-19

Animated video providing 5 tips to help stop the spread of COVID-19

Learn More
March 25, 2021

Effective Communications: The “Secret Sauce” for COVID-19 Vaccination

The COVID-19 pandemic has confronted health communicators with unprecedented challenges. To achieve widespread “vaccine literacy,” health communicators must apply basic educational principles to promote trustworthy, straightforward communication …

Learn More
Surveys and Publications

COVID-19 Communications: Promoting Prevention Measures and Vaccine Confidence

Report offering a scalable approach with strategies and messaging for COVID-19 education and outreach efforts (March 2021)

Learn More
March 23, 2021

NFID Releases New Communications Framework to Promote COVID-19 Prevention Measures

Guidance Reflects Expertise from Leading Healthcare, Business, Union, and Education Groups Bethesda, MD (March 23, 2021)—The National Foundation for Infectious Diseases (NFID) issued a new…

Learn More
March 18, 2021

ID News Round-Up: #COVID-19 Vaccination

A nationwide COVID-19 vaccination program is currently underway in the US. Where can you get vaccinated and when? What side effects can you expect? Will COVID-19 vaccines help end the pandemic? Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 vaccination …

Learn More
March 4, 2021

Schaffner Report: New COVID-19 Vaccine and Other ACIP Updates

The Advisory Committee on Immunization Practices (ACIP) recently held two important meetings to review data on vaccines for influenza, hepatitis, pneumococcal disease, shingles, and other diseases, and to approve the new Janssen COVID-19 vaccine. Marla Dalton, executive director and CEO of the National Foundation for Infectious Diseases (NFID), talks with NFID Medical Director William Schaffner, MD, about the significance of these meetings for healthcare professionals and the public …

Learn More
February 28, 2021

Black History Month: Vaccine Voices for COVID-19 Vaccine Choices

As we continue to tackle health equity issues, it is important to be open to embracing new partners and creating new champions. Although highlighting the contributions of Black scientists during Black History Month is important, addressing health equity can and should be done anytime and anywhere …

Learn More
  • « Previous
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 15
  • Next »

Subscribe to NFID Updates

Subscribe
nfid-logo@2x

7201 Wisconsin Avenue
Suite 750
Bethesda, MD 20814
Phone: 301.656.0003

NFID Facebook Profile NFID Twitter Profile NFID LinkedIn Profile NFID Youtube Account Link NFID Instagram Account

1629 K Street, NW
Suite 300
Washington, DC 20006

Founded in 1973, the National Foundation for Infectious Diseases (NFID) is an independent non-profit 501(c)(3) organization dedicated to educating and engaging the public, communities, and healthcare professionals about infectious diseases across the lifespan.

This website is designed to provide education to the public and healthcare professionals about infectious diseases across the lifespan. All information on this site is for general purposes only, is based on US recommendations, and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Contact a healthcare professional if you have questions or concerns about your health.

Federal EIN: 23-7198530

  • Education and Events
  • News and Updates
  • Partnerships
  • About NFID
  • Infectious Diseases
  • Immunization
  • COVID-19
  • Antibiotic Resistance
  • Resources
  • Contact Us
  • Support NFID
  • Privacy Policy
  • Accessibility
  • Disclaimer
Four-Star Rating Badge - Full Color
Platinum Transparency Seal 2023 Candid
vaccine-safety-net
Scroll To Top